By expenditures
| Name | Title | Type |
|---|---|---|
| Melissa Hull | Director | Auditee |
| Brenda Burgess | VP FOR ADMINISTRATION AND FINANCE | Auditee |
| Kirk Vanderslice | Partner | Auditee |
| Lori Boyd | Vice-President for Administration and Finance | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 347517 | 2024 | 2025-03-24 | Forvis Mazars LLP | $34.50M |
| 11224 | 2023 | 2024-01-12 | Hinkle & Company PC | $35.21M |
| 51788 | 2022 | 2023-01-04 | Hinkle & Company PC | $35.32M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 347517 | 2024 | 2025-03-24 | 1105969 | 2024-004 | Significant Deficiency | - | P |
| 347517 | 2024 | 2025-03-24 | 1105968 | 2024-003 | Significant Deficiency | - | N |
| 347517 | 2024 | 2025-03-24 | 1105967 | 2024-002 | Significant Deficiency | - | N |
| 347517 | 2024 | 2025-03-24 | 1105966 | 2024-002 | Significant Deficiency | - | N |
| 347517 | 2024 | 2025-03-24 | 1105965 | 2024-004 | Significant Deficiency | - | P |
| 347517 | 2024 | 2025-03-24 | 1105964 | 2024-002 | Significant Deficiency | - | N |
| 347517 | 2024 | 2025-03-24 | 1105963 | 2024-004 | Significant Deficiency | - | P |
| 347517 | 2024 | 2025-03-24 | 1105962 | 2024-003 | Significant Deficiency | - | N |
| 347517 | 2024 | 2025-03-24 | 1105961 | 2024-002 | Significant Deficiency | - | N |
| 347517 | 2024 | 2025-03-24 | 529527 | 2024-004 | Significant Deficiency | - | P |
| 347517 | 2024 | 2025-03-24 | 529526 | 2024-003 | Significant Deficiency | - | N |
| 347517 | 2024 | 2025-03-24 | 529525 | 2024-002 | Significant Deficiency | - | N |
| 347517 | 2024 | 2025-03-24 | 529524 | 2024-002 | Significant Deficiency | - | N |
| 347517 | 2024 | 2025-03-24 | 529523 | 2024-004 | Significant Deficiency | - | P |
| 347517 | 2024 | 2025-03-24 | 529522 | 2024-002 | Significant Deficiency | - | N |
| 347517 | 2024 | 2025-03-24 | 529521 | 2024-004 | Significant Deficiency | - | P |
| 347517 | 2024 | 2025-03-24 | 529520 | 2024-003 | Significant Deficiency | - | N |
| 347517 | 2024 | 2025-03-24 | 529519 | 2024-002 | Significant Deficiency | - | N |